{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:49:43Z","timestamp":1793213383626,"version":"4.5.0"},"reference-count":32,"publisher":"e-Century Publishing Corporation","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/mbfd3367","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T02:52:03Z","timestamp":1748573523000},"page":"3476-3484","source":"Crossref","is-referenced-by-count":7,"title":["Plasma glial fibrillary acidic protein as a biomarker of blood-brain barrier integrity in patients with occult cerebral small vessel disease"],"prefix":"10.62347","volume":"17","author":[{"given":"Peiqi","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/WCO.0000000000000913","article-title":"Cerebral small vessel disease and vascular cognitive impairment: from diagnosis to management","volume":"34","author":"Zanon Zotin","year":"2021","unstructured":"Zanon Zotin MC, Sveikata L, Viswanathan A and Yilmaz P. Cerebral small vessel disease and vascular cognitive impairment: from diagnosis to management. Curr Opin Neurol 2021; 34: 246-257.","journal-title":"Curr Opin Neurol"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Nam KW, Kwon HM, Lim JS, Han MK, Nam H and Lee YS. The presence and severity of cerebral small vessel disease increases the frequency of stroke in a cohort of patients with large artery occlusive disease. PLoS One 2017; 12: e0184944.","DOI":"10.1371\/journal.pone.0184944"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1093\/brain\/awab003","article-title":"Microglial activation and blood-brain barrier permeability in cerebral small vessel disease","volume":"144","author":"Walsh","year":"2021","unstructured":"Walsh J, Tozer DJ, Sari H, Hong YT, Drazyk A, Williams G, Shah NJ, O’Brien JT, Aigbirhio FI, Rosenberg G, Fryer TD and Markus HS. Microglial activation and blood-brain barrier permeability in cerebral small vessel disease. Brain 2021; 144: 1361-1371.","journal-title":"Brain"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.jalz.2019.01.013","article-title":"Quantifying blood-brain barrier leakage in small vessel disease: review and consensus recommendations","volume":"15","author":"Thrippleton","year":"2019","unstructured":"Thrippleton MJ, Backes WH, Sourbron S, Ingrisch M, van Osch MJP, Dichgans M, Fazekas F, Ropele S, Frayne R, van Oostenbrugge RJ, Smith EE and Wardlaw JM. Quantifying blood-brain barrier leakage in small vessel disease: review and consensus recommendations. Alzheimers Dement 2019; 15: 840-858.","journal-title":"Alzheimers Dement"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Wong SM, Jansen JFA, Zhang CE, Hoff EI, Staals J, van Oostenbrugge RJ and Backes WH. Blood-brain barrier impairment and hypoperfusion are linked in cerebral small vessel disease. Neurology 2019; 92: e1669-e1677.","DOI":"10.1212\/WNL.0000000000007263"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1146\/annurev-cellbio-100617-062608","article-title":"Development and cell biology of the blood-brain barrier","volume":"35","author":"UH","year":"2019","unstructured":"Langen UH, Ayloo S and Gu C. Development and cell biology of the blood-brain barrier. Annu Rev Cell Dev Biol 2019; 35: 591-613.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.cell.2015.10.067","article-title":"Establishment and dysfunction of the blood-brain barrier","volume":"163","author":"Zhao","year":"2015","unstructured":"Zhao Z, Nelson AR, Betsholtz C and Zlokovic BV. Establishment and dysfunction of the blood-brain barrier. Cell 2015; 163: 1064-1078.","journal-title":"Cell"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00441-008-0658-9","article-title":"Brain endothelial cells and the glio-vascular complex","volume":"335","author":"Wolburg","year":"2009","unstructured":"Wolburg H, Noell S, Mack A, Wolburg-Buchholz K and Fallier-Becker P. Brain endothelial cells and the glio-vascular complex. Cell Tissue Res 2009; 335: 75-96.","journal-title":"Cell Tissue Res"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1002\/glia.23908","article-title":"Astrocytes are necessary for blood-brain barrier maintenance in the adult mouse brain","volume":"69","author":"Heithoff","year":"2021","unstructured":"Heithoff BP, George KK, Phares AN, Zuidhoek IA, Munoz-Ballester C and Robel S. Astrocytes are necessary for blood-brain barrier maintenance in the adult mouse brain. Glia 2021; 69: 436-472.","journal-title":"Glia"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1002\/glia.23734","article-title":"Neurochemical regulation of the expression and function of glial fibrillary acidic protein in astrocytes","volume":"68","author":"Li","year":"2020","unstructured":"Li D, Liu X, Liu T, Liu H, Tong L, Jia S and Wang YF. Neurochemical regulation of the expression and function of glial fibrillary acidic protein in astrocytes. Glia 2020; 68: 878-897.","journal-title":"Glia"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.pneurobio.2011.01.005","article-title":"GFAP in health and disease","volume":"93","author":"Middeldorp","year":"2011","unstructured":"Middeldorp J and Hol EM. GFAP in health and disease. Prog Neurobiol 2011; 93: 421-443.","journal-title":"Prog Neurobiol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"108624","DOI":"10.1016\/j.intimp.2022.108624","article-title":"Serum glial fibrillary acidic protein is a body fluid biomarker: a valuable prognostic for neurological disease - a systematic review","volume":"107","author":"Heimfarth","year":"2022","unstructured":"Heimfarth L, Passos FRS, Monteiro BS, Araújo AAS, Quintans Júnior LJ and Quintans JSS. Serum glial fibrillary acidic protein is a body fluid biomarker: a valuable prognostic for neurological disease - a systematic review. Int Immunopharmacol 2022; 107: 108624.","journal-title":"Int Immunopharmacol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1001\/jamaneurol.2021.3671","article-title":"Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the alzheimer disease continuum","volume":"78","author":"Bened","year":"2021","unstructured":"Benedet AL, Milà-Alomà M, Vrillon A, Ashton NJ, Pascoal TA, Lussier F, Karikari TK, Hourregue C, Cognat E, Dumurgier J, Stevenson J, Rahmouni N, Pallen V, Poltronetti NM, Salvadó G, Shekari M, Operto G, Gispert JD, Minguillon C, Fauria K, Kollmorgen G, Suridjan I, Zimmer ER, Zetterberg H, Molinuevo JL, Paquet C, Rosa-Neto P, Blennow K and Suárez-Calvet M; Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer’s and Families (ALFA) study, and BioCogBank Paris Lariboisière cohort. Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the alzheimer disease continuum. JAMA Neurol 2021; 78: 1471-1483.","journal-title":"JAMA Neurol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.tins.2015.04.003","article-title":"Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker","volume":"38","author":"Yang","year":"2015","unstructured":"Yang Z and Wang KK. Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker. Trends Neurosci 2015; 38: 364-374.","journal-title":"Trends Neurosci"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.3390\/biomedicines10081869","article-title":"Association of serum GFAP with functional and neurocognitive outcome in sporadic small vessel disease","volume":"10","author":"Huss","year":"2022","unstructured":"Huss A, Abdelhak A, Mayer B, Tumani H, Müller HP, Althaus K, Kassubek J, Otto M, Ludolph AC, Yilmazer-Hanke D and Neugebauer H. Association of serum GFAP with functional and neurocognitive outcome in sporadic small vessel disease. Biomedicines 2022; 10: 1869.","journal-title":"Biomedicines"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","article-title":"Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration","volume":"12","author":"JM","year":"2013","unstructured":"Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI, O’Brien JT, Barkhof F, Benavente OR, Black SE, Brayne C, Breteler M, Chabriat H, Decarli C, de Leeuw FE, Doubal F, Duering M, Fox NC, Greenberg S, Hachinski V, Kilimann I, Mok V, Oostenbrugge Rv, Pantoni L, Speck O, Stephan BC, Teipel S, Viswanathan A, Werring D, Chen C, Smith C, van Buchem M, Norrving B, Gorelick PB and Dichgans M; STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1). Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013; 12: 822-838.","journal-title":"Lancet Neurol"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Chen KL, Xu Y, Chu AQ, Ding D, Liang XN, Nasreddine ZS, Dong Q, Hong Z, Zhao QH and Guo QH. Validation of the chinese version of montreal cognitive assessment basic for screening mild cognitive impairment. J Am Geriatr Soc 2016; 64: e285-e290.","DOI":"10.1111\/jgs.14530"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1177\/0271678X17724681","article-title":"New astroglial injury-defined biomarkers for neurotrauma assessment","volume":"37","author":"Halford","year":"2017","unstructured":"Halford J, Shen S, Itamura K, Levine J, Chong AC, Czerwieniec G, Glenn TC, Hovda DA, Vespa P, Bullock R, Dietrich WD, Mondello S, Loo JA and Wanner IB. New astroglial injury-defined biomarkers for neurotrauma assessment. J Cereb Blood Flow Metab 2017; 37: 3278-3299.","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1212\/WNL.0000000000003556","article-title":"Blood-brain barrier leakage is more widespread in patients with cerebral small vessel disease","volume":"88","author":"Zhang","year":"2017","unstructured":"Zhang CE, Wong SM, van de Haar HJ, Staals J, Jansen JF, Jeukens CR, Hofman PA, van Oostenbrugge RJ and Backes WH. Blood-brain barrier leakage is more widespread in patients with cerebral small vessel disease. Neurology 2017; 88: 426-432.","journal-title":"Neurology"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1161\/STROKEAHA.110.611731","article-title":"Blood-brain barrier permeability abnormalities in vascular cognitive impairment","volume":"42","author":"Taheri","year":"2011","unstructured":"Taheri S, Gasparovic C, Huisa BN, Adair JC, Edmonds E, Prestopnik J, Grossetete M, Shah NJ, Wills J, Qualls C and Rosenberg GA. Blood-brain barrier permeability abnormalities in vascular cognitive impairment. Stroke 2011; 42: 2158-2163.","journal-title":"Stroke"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/ana.21549","article-title":"Lacunar stroke is associated with diffuse blood-brain barrier dysfunction","volume":"65","author":"JM","year":"2009","unstructured":"Wardlaw JM, Doubal F, Armitage P, Chappell F, Carpenter T, Muñoz Maniega S, Farrall A, Sudlow C, Dennis M and Dhillon B. Lacunar stroke is associated with diffuse blood-brain barrier dysfunction. Ann Neurol 2009; 65: 194-202.","journal-title":"Ann Neurol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.7150\/thno.68304","article-title":"Pathophysiology of blood brain barrier dysfunction during chronic cerebral hypoperfusion in vascular cognitive impairment","volume":"12","author":"Rajeev","year":"2022","unstructured":"Rajeev V, Fann DY, Dinh QN, Kim HA, De Silva TM, Lai MKP, Chen CL, Drummond GR, Sobey CG and Arumugam TV. Pathophysiology of blood brain barrier dysfunction during chronic cerebral hypoperfusion in vascular cognitive impairment. Theranostics 2022; 12: 1639-1658.","journal-title":"Theranostics"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","article-title":"APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline","volume":"581","author":"Montagne","year":"2020","unstructured":"Montagne A, Nation DA, Sagare AP, Barisano G, Sweeney MD, Chakhoyan A, Pachicano M, Joe E, Nelson AR, D’Orazio LM, Buennagel DP, Harrington MG, Benzinger TLS, Fagan AM, Ringman JM, Schneider LS, Morris JC, Reiman EM, Caselli RJ, Chui HC, Tcw J, Chen Y, Pa J, Conti PS, Law M, Toga AW and Zlokovic BV. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. Nature 2020; 581: 71-76.","journal-title":"Nature"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1016\/j.jalz.2018.06.2857","article-title":"Blood-brain barrier breakdown, neuroinflammation, and cognitive decline in older adults","volume":"14","author":"Bowman","year":"2018","unstructured":"Bowman GL, Dayon L, Kirkland R, Wojcik J, Peyratout G, Severin IC, Henry H, Oikonomidi A, Migliavacca E, Bacher M and Popp J. Blood-brain barrier breakdown, neuroinflammation, and cognitive decline in older adults. Alzheimers Dement 2018; 14: 1640-1650.","journal-title":"Alzheimers Dement"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1002\/alz.12447","article-title":"Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer’s disease","volume":"18","author":"Chatterjee","year":"2022","unstructured":"Chatterjee P, Pedrini S, Ashton NJ, Tegg M, Goozee K, Singh AK, Karikari TK, Simrén J, Vanmechelen E, Armstrong NJ, Hone E, Asih PR, Taddei K, Doré V, Villemagne VL, Sohrabi HR, Zetterberg H, Masters CL, Blennow K and Martins RN. Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer’s disease. Alzheimers Dement 2022; 18: 1141-1154.","journal-title":"Alzheimers Dement"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1007\/s00414-021-02568-1","article-title":"GFAP positivity in neurons following traumatic brain injuries","volume":"135","author":"Zwirner","year":"2021","unstructured":"Zwirner J, Lier J, Franke H, Hammer N, Matschke J, Trautz F, Tse R and Ondruschka B. GFAP positivity in neurons following traumatic brain injuries. Int J Legal Med 2021; 135: 2323-2333.","journal-title":"Int J Legal Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s11060-018-2898-1","article-title":"Pre- and early postoperative GFAP serum levels in glioma and brain metastases","volume":"139","author":"Baumgarten","year":"2018","unstructured":"Baumgarten P, Quick-Weller J, Gessler F, Wagner M, Tichy J, Forster MT, Foerch C, Seifert V, Mittelbronn M and Senft C. Pre- and early postoperative GFAP serum levels in glioma and brain metastases. J Neurooncol 2018; 139: 541-546.","journal-title":"J Neurooncol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.immuni.2017.06.006","article-title":"Reactive astrocytes: production, function, and therapeutic potential","volume":"46","author":"Liddelow","year":"2017","unstructured":"Liddelow SA and Barres BA. Reactive astrocytes: production, function, and therapeutic potential. Immunity 2017; 46: 957-967.","journal-title":"Immunity"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3233\/JAD-200541","article-title":"High cholesterol diet exacerbates blood-brain barrier disruption in LDLr-\/- mice: impact on cognitive function","volume":"78","author":"de Oliveira","year":"2020","unstructured":"de Oliveira J, Engel DF, de Paula GC, Dos Santos DB, Lopes JB, Farina M, Moreira ELG and de Bem AF. High cholesterol diet exacerbates blood-brain barrier disruption in LDLr-\/- mice: impact on cognitive function. J Alzheimers Dis 2020; 78: 97-115.","journal-title":"J Alzheimers Dis"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1007\/s11095-021-03098-6","article-title":"Interactions of lipids, lipoproteins, and apolipoproteins with the blood-brain barrier","volume":"38","author":"Rhea","year":"2021","unstructured":"Rhea EM and Banks WA. Interactions of lipids, lipoproteins, and apolipoproteins with the blood-brain barrier. Pharm Res 2021; 38: 1469-1475.","journal-title":"Pharm Res"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"109324","DOI":"10.1155\/2012\/109324","article-title":"Simvastatin blocks blood-brain barrier disruptions induced by elevated cholesterol both in vivo and in vitro","volume":"2012","author":"Jiang","year":"2012","unstructured":"Jiang X, Guo M, Su J, Lu B, Ma D, Zhang R, Yang L, Wang Q, Ma Y and Fan Y. Simvastatin blocks blood-brain barrier disruptions induced by elevated cholesterol both in vivo and in vitro. Int J Alzheimers Dis 2012; 2012: 109324.","journal-title":"Int J Alzheimers Dis"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.tem.2022.03.001","article-title":"Metabolic changes favor the activity and heterogeneity of reactive astrocytes","volume":"33","author":"XY","year":"2022","unstructured":"Xiong XY, Tang Y and Yang QW. Metabolic changes favor the activity and heterogeneity of reactive astrocytes. Trends Endocrinol Metab 2022; 33: 390-400.","journal-title":"Trends Endocrinol Metab"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/5\/ajtr0163035.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:57:40Z","timestamp":1766023060000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/5\/ajtr0163035.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":32,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/mbfd3367","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}